Hospital CEOs Face Questions Over "Borderline Extortion" Pricing
Why it matters: The House Ways and Means Committee put the nation's largest hospital systems on the hot seat Tuesday, with Chair Jason Smith (R-MO) telling...
Why it matters: The House Ways and Means Committee put the nation's largest hospital systems on the hot seat Tuesday, with Chair Jason Smith (R-MO) telling...
A Senate bid to protect patients from insurance company delays and denials of medical care collapsed Wednesday when floor vote 1192s97 failed to clear the...
The Children's Hospital Association filed a First Quarter 2026 lobbying disclosure reporting $1.44 million in federal lobbying expenditures, as the...
Why it matters: The Senate Appropriations Subcommittee on Labor, HHS, Education, and Related Agencies convened Tuesday, April 21, for an HHS FY2027 budget...
PMI US Corporate Services Inc. filed an amended lobbying disclosure for the First Quarter of 2026, reporting $2.38 million in in-house lobbying activity....
Novo Nordisk Inc. ended its lobbying relationship with Public Strategies Washington Inc. effective February 1, 2026, according to a Q1 2026 LDA filing...
Federal funding for the Indian Health Service sits at the center of a long-standing debate over whether the U.S. government is meeting its trust and treaty...
The House Ways and Means Committee is bringing health system CEOs to Capitol Hill at a moment when Congress is actively reshaping the federal budget, with...
The Improving Care in Rural America Reauthorization Act clears the House 406-4, with both parties aligned on extending federal grants through 2030.
Medicare fraud costs the federal government tens of billions of dollars annually — money that flows out of a program serving more than 65 million Americans....
Zimmer Biomet Holdings Inc. filed its First Quarter 2026 lobbying disclosure this week, reporting $185,000 in in-house lobbying expenditures — but with a...
A package of ten public health bills — covering everything from ALS research to school-based health clinics to tick-borne disease — lands before the House...
Pharmacy benefit managers — the largely invisible intermediaries that negotiate drug prices between manufacturers, insurers, and pharmacies — are facing a...
The House Energy and Commerce Subcommittee on Health is set to examine the FY 2027 HHS Budget on April 21 — a hearing that arrives as Congress wrestles with...
Why it matters: The House Energy and Commerce Subcommittee on Health convened April 15 to examine ten public health bills — from ALS research to...
An amendment to recognize polycystic ovary syndrome failed Friday along strict party lines, 208-199, in a vote that exposed deep divisions over women's...
The Michael J. Fox Foundation for Parkinson's Research filed its First Quarter 2026 lobbying disclosure, reporting $190,000 in in-house lobbying...
The Senate Health, Education, Labor, and Pensions Committee is set to examine the White House's Fiscal Year 2027 budget request for the Department of Health...